Iroquois Capital Management LLC 13D and 13G filings for Artelo Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-23 4:36 pm Sale | 2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Iroquois Capital Management LLC | 6,667 0.240% | -54,667 (-89.13%) | Filing |
| 2020-10-19 3:25 pm Purchase | 2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL | Iroquois Capital Management LLC | 61,333 6.670% | 61,333 (New Position) | Filing |